Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank

By Chris Katje
March 11, 3:27 PM
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the company’s Silicon Valley Bank.

AMBA

Read More
1 minute read
  • News

Neuronetics Says Co Holds Less Than $1B In Cash With SVB

By Benzinga Newsdesk
March 10, 6:49 PM
-SEC Filing

SIVB

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

JMP Securities Reiterates Market Outperform on Neuronetics, Maintains $12 Price Target

By Benzinga Newsdesk
March 8, 8:26 AM
JMP Securities analyst David Turkaly reiterates Neuronetics (NASDAQ:STIM) with a Market Outperform and maintains $12 price target.

STIM

Read More
1 minute read
  • Earnings
  • News

Neuronetics Q4 EPS $(0.30) Beats $(0.38) Estimate, Sales $18.20M Beat $16.82M Estimate

By Benzinga Newsdesk
March 7, 8:31 AM
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.38) by 21.05 percent. This is a 3.45 percent decrease over losses of $(0.29) per share from the

STIM

Read More
1 minute read
  • Contracts
  • General
  • Health Care
  • News
  • Penny Stocks

Neuronetics Inks Six-Year Exclusive Partnership With Greenbrook TMS

By Vandana Singh
January 19, 11:50 AM
Neuronetics Inc (NASDAQ:STIM) and Greenbrook TMS Inc (NASDAQ:GBNH) announced an expanded commercial partnership through year-end 2028. Under the partnership agreement, Neuronetics will…

GBNH

Read More
1 minute read
  • General
  • Health Care
  • Legal
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Neuronetics Settles Unfair Competition Related Litigation Against BrainsWay

By Vandana Singh
January 10, 1:27 PM
Neuronetics Inc (NASDAQ:STIM) settled the litigation filed in the District of Delaware against BrainsWay Ltd (NASDAQ:BWAY) and BrainsWay USA Inc. for unfair competition. Under the…

BWAY

Read More
8 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
December 1, 1:10 PM
  During Thursday's session, 108 stocks hit new 52-week highs.

ABC

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights
November 17, 1:32 PM
Gainers Ardelyx (NASDAQ:ARDX) shares moved upwards by 53.3% to $1.87 during Thursday’s regular session. Trading volume for Ardelyx’s…

AHPI

Read More
21 minute read
  • Earnings

Earnings Scheduled For November 8, 2022

By Benzinga Insights
November 8, 5:32 AM
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

ABCL

Read More
5 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin
September 29, 5:09 AM
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.

ABOS

Posts navigation

1 2 … 9 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service